DNTH Competitors & Alternatives
Compare Dianthus Therapeutics Inc. with similar stocks in the same industry
Biotechnology
DNTH
Main Stock$76.79
Tradestie Score
56
Market Cap
$1.55B
Revenue Growth
2.9%
Analyst Upside
+83.4%
Top Competitors
219 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
PCVX
Vaxcyte, Inc. Common Stock
|
$62.35
|
$4.94B | - | 42 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$63.02
|
$4.93B | - | 57 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$57.88
|
$4.84B | - | 60 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 50 | Compare |
|
PTGX
Protagonist Therapeutics, Inc
|
$139.68
|
$3.98B | 134.0 | 64 | Compare |
|
CRNX
Crinetics Pharmaceuticals, Inc.
|
$84.95
|
$3.92B | - | 46 | Compare |
|
KYMR
Kymera Therapeutics, Inc. Common Stock
|
$111.25
|
$3.91B | - | 58 | Compare |
|
ZLAB
Zai Lab Limited American Depositary Shares
|
$21.78
|
$3.83B | - | 54 | Compare |
|
AAPG
Ascentage Pharma Group International American Depository Shares
|
$15.10
|
$3.68B | - | 47 | Compare |
|
MIRM
Mirum Pharmaceuticals, Inc. Common Stock
|
$82.95
|
$3.67B | - | 68 | Compare |
More DNTH Analysis
Data updated: Oct 22, 2026 | Industry: Biotechnology (SIC 2834)
219 stocks in this industry